$146.09 0.00 (0.00%)

ZOETIS INC. (ZTS)

Zoetis Inc. (ZTS) is a global leader in animal health, providing a wide range of pharmaceutical, vaccine, and diagnostic products for livestock and companion animals. Established in 1952 and becoming an independent company in 2013, Zoetis develops innovative solutions to improve animal health and well-being, supporting the needs of veterinarians, pet owners, and livestock producers worldwide.

Dividend Yield 1.37%
Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $0.50 per share, scheduled to be distributed in 41 days on December 2, 2025

Pay DateAmountEx-DateRecord Date
December 2, 2025$0.502025-10-312025-10-31
September 3, 2025$0.502025-07-182025-07-18
June 3, 2025$0.502025-04-212025-04-21
March 4, 2025$0.502025-01-212025-01-21
December 3, 2024$0.432024-10-312024-10-31

Dividends Summary

Company News

Pet Cancer Therapeutics Market Size Worth USD 1,150.70 Million by 2034
GlobeNewswire Inc. • Precedence Research • October 22, 2025

The global pet cancer therapeutics market is projected to grow from $493 million in 2025 to $1.15 billion by 2034, driven by increasing pet cancer awareness, advanced veterinary treatments, and growing pet humanization trends.

2 Magnificent Dividend Stocks to Buy Now and Hold Forever
The Motley Fool • Prosper Junior Bakiny • October 8, 2025

The article discusses two dividend stocks with strong long-term potential: Mastercard and Zoetis. Both companies demonstrate consistent growth, strong market positioning, and impressive dividend increase histories.

Zoetis Beats Wall Street Estimates, Revises 2025 Guidance To Include Tariffs Impact
Benzinga • Vandana Singh • May 6, 2025

Zoetis reported strong Q1 2025 results, beating Wall Street estimates. The company also revised its FY2025 guidance, raising the adjusted EPS range to $6.20-$6.30, above the previous guidance and consensus.

USNA or ZTS: Which Is the Better Value Stock Right Now?
Zacks Investment Research • Zacks Equity Research • June 21, 2024

USNA vs. ZTS: Which Stock Is the Better Value Option?

My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
Seeking Alpha • Nicholas Ward • May 13, 2024

I have shifted my strategy to focus on quality rather than value and have been buying big-tech stocks. Read more to see a review of my portfolio.

Related Companies